With 2.81 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.63 million shares. The 52-week range on ERAS shows that it touched its highest point at $3.45 and its lowest point at $1.01 during that stretch. It currently has a 1-year price target of $5.19. Beta for the stock currently stands at 1.13.
Price Performance and Earnings:
Three-month performance dropped to -33.06% while six-month performance fell -54.96%. The stock lost -42.76% in the past year, while it has lost -51.20% so far this year. A look at the trailing 12-month EPS for ERAS yields -0.75 with Next year EPS estimates of -0.60. For the next quarter, that number is -0.12. This implies an EPS growth rate of 22.33% for this year and -12.86% for next year. EPS is expected to grow by 6.59% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -46.86%.
Float and Shares Shorts:
At present, 283.22 million ERAS shares are outstanding with a float of 163.76 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ERAS since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.68873 being high and -$0.83846 being low. For ERAS, this leads to a yearly average estimate of -$0.72866.
